FUT8 and metabolic dysfunction-associated steatotic liver disease: We and others have shown that core fucosylation, catalyzed by alpha-1,6-fucosyltransferase (FUT8), is one of the main N-glycan modifications in early liver disease like nonalcoholic fatty liver disease and liver cancers (7, 41–43).